序号 |
标题 |
次数 |
作者 |
发布时间 |
76006 |
NH2-PEG8-C6-Cl,3024055-47-5 |
107 |
h |
2024-12-23 |
76007 |
NH2-PEG6-C6-Cl,1261350-61-1 |
108 |
h |
2024-12-23 |
76008 |
Me-Diazirine-C6-OH,493008-72-3 |
105 |
h |
2024-12-23 |
76009 |
Cyanine5-C6-DBCO,2360411-64-7 |
130 |
h |
2024-12-23 |
76010 |
Azido-PEG10-C6-Cl,叠氮-PEG10-C6-Cl |
223 |
h |
2024-12-23 |
76011 |
Thiol-PEG4-t-butyl ester,564476-33-1 |
94 |
h |
2024-12-23 |
76012 |
Amino-PEG12-C6,氨基-PEG12-C6 |
126 |
h |
2024-12-23 |
76013 |
Amino-PEG4-C6,3024055-44-2 |
118 |
h |
2024-12-23 |
76014 |
Thalidomide-O-C6-acid,2169266-69-5 |
83 |
h |
2024-12-23 |
76015 |
NOTA-C6-amine,NOTA-C6-氨基 |
115 |
h |
2024-12-23 |
76016 |
Me-Diazirine-C7-OH,1823865-63-9,甲基-双吖丙啶-C7-羟基 |
117 |
h |
2024-12-23 |
76017 |
m-PEG12-C11-SH,甲基-十二聚乙二醇-C11-巯基 |
97 |
h |
2024-12-23 |
76018 |
m-PEG4-C11-SH,200880-89-3,甲基-四聚乙二醇-C11-巯基 |
137 |
h |
2024-12-23 |
76019 |
m-PEG8-C11-SH,甲基-八聚乙二醇-C11-巯基 |
89 |
h |
2024-12-23 |
76020 |
(S,R,S)-AHPC-C10-NH2,CAS:2341796-74-3,(S,R,S)-AHPC-C10-胺 |
136 |
h |
2024-12-23 |
76021 |
(S,R,S)-AHPC-C9-azide,2906183-84-2,(S,R,S)-AHPC-C9-叠氮 |
127 |
h |
2024-12-23 |
76022 |
(S,R,S)-AHPC-C8-azide,2906183-83-1,(S,R,S)-AHPC-C8-叠氮 |
158 |
h |
2024-12-20 |
76023 |
m-PEG9-(CH2)8-Phosphonic acid,2900307-00-6,甲基-九聚乙二醇-C8-膦酸 |
134 |
h |
2024-12-20 |
76024 |
m-PEG2-(CH2)8-Phosphonic acid,2227008-55-9,甲基-二聚乙二醇-C8-膦酸 |
140 |
h |
2024-12-20 |
76025 |
m-PEGn-(CH2)8-Phosphonic acid,甲基-聚乙二醇-C8-膦酸 |
167 |
h |
2024-12-20 |
76026 |
Bio-PEG3-C14-鞘氨醇,生物-三聚乙二醇-C14-鞘氨醇 |
129 |
h |
2024-12-20 |
76027 |
NHS-C16-COOH,146004-84-4,琥珀酰亚胺酯-C16-酸 |
196 |
h |
2024-12-20 |
76028 |
DBCO-CONH-PEG4-Maleimide |
112 |
h |
2024-12-20 |
76029 |
cas:2130869-17-7,VCP-Eribulin , ADC试剂 |
119 |
kx |
2024-12-20 |
76030 |
cas:452072-20-7,SPP-DM1 ,抗体药物偶联物(ADC) |
134 |
kx |
2024-12-20 |
76031 |
1810001-93-4,DBM-MMAF,抗体药物偶联物(ADC) |
182 |
kx |
2024-12-20 |
76032 |
Fmoc-Gln(Trt)-PAB-PNP, ADC试剂 |
134 |
kx |
2024-12-20 |
76033 |
cas:330970-70-2,Alloc-Val-Ala-OH,((烯丙氧基)羰基)-L-戊基-L-丙氨酸 |
141 |
kx |
2024-12-20 |
76034 |
cas:2055041-40-0,Azido-PEG1-Val-Cit-PAB-OH, ADC试剂 |
96 |
kx |
2024-12-20 |
76035 |
DBCO-C4-Val-Cit-PABC-PNP,抗体药物偶联物(ADC) |
143 |
kx |
2024-12-20 |
76036 |
cas:2243566-44-9,Azidoethyl-SS-propionic NHS ester,叠氮-二硫键-琥珀酰亚胺酯 |
172 |
kx |
2024-12-20 |
76037 |
MEL-tri-EG-OPFP,抗体药物偶联物(ADC) |
206 |
kx |
2024-12-20 |
76038 |
Pomalidomide-C6-COOH,2225940-50-9 |
107 |
wyh |
2024-12-20 |
76039 |
cas:799840-96-3,Maytansinoid DM4,N2'-去乙酰基-N2'-(4-巯基-4-甲基-1-氧代戊基)-6-甲基美登素 |
156 |
kx |
2024-12-20 |
76040 |
Cl-C6-PEG1-O-CH2COOH,2231744-57-1,氯-C6-一聚乙二醇-O-乙酸 |
108 |
wyh |
2024-12-20 |
76041 |
Amino-PEG1-C6 (HCl salt),1802310-46-8 |
109 |
wyh |
2024-12-20 |
76042 |
cas:114390-30-6,N-(Iodoacetamido)-Doxorubicin, ADC试剂 |
141 |
kx |
2024-12-20 |
76043 |
Azido-PEG5-C6-Cl,1261238-21-4,叠氮-五聚乙二醇-C6-氯 |
110 |
wyh |
2024-12-20 |
76044 |
cas:1226050-10-7,N-(2-(4-Chlorophenoxy)ethyl)-4-formylbenzamide |
151 |
kx |
2024-12-20 |
76045 |
DBCO-C3-Maleimide,1629057-08-4 |
132 |
h |
2024-12-20 |
76046 |
cas:663599-00-6,NO2-SPDMV-sulfo, ADC试剂 |
134 |
kx |
2024-12-20 |
76047 |
CAS:118162-45-1 N3-C10-COOH 叠氮-C10-酸 |
145 |
h |
2024-12-20 |
76048 |
Biotin-PEG-C14 生物素聚乙二醇C14 |
113 |
h |
2024-12-20 |
76049 |
NH2-PEG2000-C16 palmitic acid 氨基-聚乙二醇-棕榈酸 |
87 |
h |
2024-12-20 |
76050 |
cas:1428629-70-2,Propargyl-PEG4-NHS ester,丙炔基-三聚乙二醇-丙烯酸琥珀酰亚胺酯 |
201 |
kx |
2024-12-20 |